Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders - Part I.

Bead layering Dissolution enhancement DoE Downstream processing Enabling technology Irbesartan (PubChem CID: 3749) Nanocrystalline suspensions Poor solubility Spray granulation

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
10 Sep 2019
Historique:
received: 21 11 2018
revised: 01 03 2019
accepted: 03 03 2019
pubmed: 10 3 2019
medline: 25 1 2020
entrez: 10 3 2019
Statut: ppublish

Résumé

Nanocrystalline suspensions offer a promising approach to improve the dissolution rate of BCS Class II/IV drugs and hence oral bioavailability. Irbesartan (crystalline Form B), a poorly soluble drug substance was chosen as a model compound for the study. The objectives of the study were to formulate Irbesartan nanocrystalline suspension via media milling, study the effects of process and formulation variables on particle size reduction, and evaluate bead layering or spray granulation as drying processes. A Design of Experiment approach was utilized to understand the impact of formulation variables on particle size reduction via media milling. Drug concentration and type of stabilizer were found to be significant in particle size reduction. Optimized Irbesartan nanocrystalline suspension (i.e. at 10% w/w with 1% w/w poloxamer 407) showed superior in vitro dissolution profile compared to unmilled suspension. Optimized Irbesartan nanocrystalline suspension was converted into dried powders either by bead layering (with microcrystalline cellulose) or by spray granulation (either with mannitol or microcrystalline cellulose). DSC and PXRD studies revealed that Irbesartan remained crystalline post drying. Microcrystalline cellulose beads layered with Irbesartan nanocrystals showed about 65% drug dissolution within the first 10 min of dissolution study. Mannitol granules containing Irbesartan nanocrystals were fast dissolving (i.e. >90% drug dissolution within 10 min) compared to microcrystalline cellulose granules (i.e. approx. 46% drug dissolution within 10 min). Irbesartan nanocrystalline suspension had the fastest dissolution rates (i.e. >90% drug dissolution in two minutes) followed by mannitol-based granules containing dried Irbesartan nanocrystals (i.e. >90% drug dissolution in ten minutes).

Identifiants

pubmed: 30851385
pii: S0378-5173(19)30183-8
doi: 10.1016/j.ijpharm.2019.03.007
pii:
doi:

Substances chimiques

Antihypertensive Agents 0
Powders 0
Mannitol 3OWL53L36A
Cellulose 9004-34-6
Irbesartan J0E2756Z7N
microcrystalline cellulose OP1R32D61U

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118189

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Saikishore Meruva (S)

College of Pharmacy, University of Iowa, 115 S. Grand Avenue, Iowa City, IA 52242, USA.

Prajwal Thool (P)

Drug Product Development, Celgene, 556 Morris Avenue, Summit, NJ 07901, USA.

Shawreen Shah (S)

Drug Product Development, Celgene, 556 Morris Avenue, Summit, NJ 07901, USA.

Shyam Karki (S)

Drug Product Development, Celgene, 556 Morris Avenue, Summit, NJ 07901, USA.

William Bowen (W)

Drug Product Development, Celgene, 556 Morris Avenue, Summit, NJ 07901, USA.

Indrajit Ghosh (I)

Drug Product Development, Celgene, 556 Morris Avenue, Summit, NJ 07901, USA.

Sumit Kumar (S)

Drug Product Development, Celgene, 556 Morris Avenue, Summit, NJ 07901, USA. Electronic address: sumikumar@celgene.com.

Articles similaires

Animals Dietary Fiber Dextran Sulfate Mice Disease Models, Animal
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Tumor Microenvironment Nanoparticles Immunotherapy Cellular Senescence Animals
Cobalt Azo Compounds Ferric Compounds Polyesters Photolysis

Classifications MeSH